426 results on '"Han, B."'
Search Results
202. 123P Long term survival analysis of osimertinib in stage IV NSCLC patients harbored acquired EGFR T790M mutation: A real-word study in China.
203. Prostate Cancer Staging and Radiation Treatment Planning Using Deep Learning on MRI.
204. 396OA multi-center, randomized, double-blind, parallel, two-group phase III trial on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in first-line treatment of non-squamous non-small cell lung cancer.
205. P1.03-30 The Number of Mutated Repair Genes as Predictor for Tumor Mutation Burden of Lung Adenocarcinoma.
206. P1.03-22 MiR-125b Plays a Tumor Suppressor Role in Inflammation-Related Non-Small Cell Lung Cancer via Repressing IGF-1 Signal Pathway.
207. P1.01-107 The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).
208. P1.01-30 Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients with ALK Rearrangement: A Retrospective Study and Literature Review.
209. P1.01-29 Crizotinib in Advanced Lung Adenocarcinoma Patients with ALK or ROS-1 Rearrangement: Is it the Same?
210. MA15.07 Different Responses to Osimertinib in Primary and Acquired EGFR T790M-Mutant NSCLC Patients.
211. MA01.01 Proposal on Incorporating Lymphovascular Invasion as a T-Descriptor for Stage I Non-Small Cell Lung Cancer.
212. OA07.06 Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.
213. JCSE01.21 Different Responses to Osimertinib in Primary and Acquired EGFR T790M-Mutant NSCLC Patients.
214. JCSE01.19 ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line.
215. P3.13-09 ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line.
216. P2.15-22 Optimal Glycemic Control Improves Prognosis for Lung Cancer Patients with Diabetes Mellitus.
217. P2.12-17 Prophylactic Cranial Irradiation Can Not Provide Survival Benefits for Resected Small Cell Lung Cancer Without Lymph Node Involvement.
218. P2.11-01 Blood Transcriptomics Enables Detection of Pre-Invasive and Minimally-Invasive Lung Adenocarcinoma.
219. P2.03-37 The Efficiency of Octamer-4 Specific Cytotoxic T Cells Induce By CD40-B Cells in Killing Lung Cancer Stem-Like Cells.
220. P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice.
221. P2.01-01 The Impact of Anlotinib on Brain Metastases of NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).
222. Novel Techniques in Imaging Congenital Heart Disease: JACC Scientific Statement.
223. 91O Adjuvant chemotherapy candidates in stage I lung adenocarcinomas following complete lobectomy: What does an analysis based on recurrence risk stratification tell us?
224. 100P Prognostic factors in surgically resected N2 small cell lung cancer: Significance of the subcarinal node.
225. 104P Adjuvant chemotherapy may improve prognosis in surgically resected stage I NSCLC with lymphovascular invasion.
226. 167P Efficacy of pemetrexed-based chemotherapy in advanced lung adenocarcinoma patients with ROS-1 rearrangement.
227. 92P Expression of TNFRII in serum is correlated with the significant risk of subcentimeter lung adenocarcinoma.
228. 61P mir-125b plays a tumor suppressor role in inflammation-related non-small cell lung cancer via repressing IGF-1 signal pathway.
229. 162P Responses to EGFR TKIs and ALK TKIs in advanced NSCLC patients harboring concomitant EGFR and ALK alterations.
230. 140PD Complex epidermal growth factor receptor (EGFR) mutations and responses to tyrosine kinase inhibitors (TKIs) in advanced lung adenocarcinomas.
231. Material Decomposition Using Triple-Energy CT for Accurate Proton Therapy Dose Calculation.
232. Regioisomeric and enantiomeric analysis of primary triglycerides in human milk by silver ion and chiral HPLC atmospheric pressure chemical ionization-MS.
233. Estrogen receptor-b expression in male coronary arteries
234. 290 - Observation of Magnetic Resonance Imaging Monitoring in Patients with Low/INT-1 Risk Myelodysplastic Syndromes or Aplastic Anemia Complicated with Iron Overload.
235. Application of digital techniques in correction of hemimandibular and condylar hyperplasia.
236. Colour Doppler ultrasound in the assessment and mapping of vessels of the anterolateral thigh flap in the reconstruction of head and neck defects.
237. Application of combined computer-aided design/computer-aided manufacturing and three-dimensional printing in mandibular reconstruction: a controlled clinical trial.
238. Development of a High-Resolution End-to-End Patient-Specific Quality Assurance Tool for Rotational Stereotactic Body Radiation Therapy Deliveries Using an Electronic Portal Imaging Device.
239. Outstanding tensile properties of a precipitation-strengthened FeCoNiCrTi0.2 high-entropy alloy at room and cryogenic temperatures.
240. 859 ZOLEDRONIC ACID AND GGTI CAN AUGMENT DOCETAXEL-INDUCED GROWTH INHIBITION IN PROSTATE CANCER CELLS
241. COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR ASSESSMENT OF ANATOMY THROUGH ALL STAGES OF SINGLE VENTRICLE PALLIATION.
242. Diagnostic Value of Contrast-Enhanced Multiphase Computed Tomography for Assessment of Percutaneous Pulmonary Valve Obstruction.
243. 1310: Combination of chemotherapy and gefitinib as first-line treatment of patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomised controlled trial.
244. 59PD Association of EGFR mutation subtypes with clinical and demographic characteristics of patients (pts) with aNSCLC: IGNITE and ASSESS pooled analysis.
245. 580_PR: Clinical and demographic features that influence EGFR mutation detection in plasma from patients (pts) with aNSCLC: The ASSESS experience.
246. Application of a Depth Sensing Technique to Total Body Irradiation (TBI) Patient Measurement and Treatment Planning.
247. ARHI could regulate the programmed cell death and malignant progressing of oral cancer cells.
248. Large full-thickness labial defects repaired by free flaps.
249. An EPID-based Dosimetric Verification Tool for Electron Beam Therapy.
250. Development of a High-Resolution and High-Efficiency Dosimetry Strategy for Robotic Radiosurgery QA.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.